Volastra Therapeutics
NY - New YorkBiotechnology
Focus: Volastra Therapeutics is an oncology-focused biotech company developing therapies for metastatic cancers. The company operates as a pre-revenue stage biotech with an early-stage pipeline.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Volastra Therapeutics?
AI assessmentVolastra represents a high-risk, high-reward early-stage oncology opportunity best suited for researchers comfortable with startup uncertainty and seeking equity participation.
Why Work Here
- Focused oncology pipeline with three active clinical programs addressing high unmet needs in advanced solid tumors and ovarian cancer.
- Early-stage company offers potential for significant equity upside and direct impact on drug development strategy.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AMG 650
Advanced Solid TumorsPhase 1
Clinical Trials (1)
Help build intelligence for Volastra Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.